Variant Synonymizer: Platform to identify mutations defined in different ways is available now!
Over 2,000 gene–disease validation summaries are now available—no login required!
Arts syndrome is a severe X-linked recessive disorder caused by loss-of-function variants in PRPS1, characterized by early-onset hypotonia, ataxia, intellectual disability, congenital sensorineural hearing loss, optic atrophy, and recurrent infections. Initial linkage and sequencing studies in Dutch and Australian families identified pathogenic missense variants c.398A>C (p.Gln133Pro) and c.455T>C (p.Leu152Pro) segregating with Arts syndrome in multiple affected males ([PMID:17701896]). Subsequent independent reports described additional hemizygous variants, including c.367C>G (p.His123Asp) in a pedigree with three affected maternal uncles ([PMID:27256512]), and c.130A>G (p.Ile44Val) in a sporadic case lacking congenital hearing loss ([PMID:33294372]).
Functional assays demonstrate that these PRPS1 variants result in markedly reduced phosphoribosyl-pyrophosphate synthetase 1 activity in patient erythrocytes and fibroblasts ([PMID:17701896]), and zebrafish prps1a/prps1b double mutants recapitulate key human phenotypes—optic atrophy, hearing impairment, peripheral neuropathy, and leukocyte deficiency—supporting a loss-of-function mechanism ([PMID:27425195]). A recent case series of four Arts syndrome patients receiving S-adenosylmethionine and nicotinamide riboside supplementation showed stabilization or improvement of neurologic and immunologic features, suggesting a potential metabolic rescue strategy ([PMID:37927483]).
Collectively, genetic evidence from at least five unrelated families and concordant experimental data establish a definitive association between PRPS1 loss-of-function variants and Arts syndrome. PRPS1 sequencing should be pursued in male infants presenting with hypotonia, developmental delay, sensorineural hearing loss, optic atrophy, and recurrent infections. Early molecular diagnosis enables family counseling for X-linked inheritance and consideration of S-adenosylmethionine-based therapy.
Gene–Disease AssociationDefinitiveFive unrelated families with co-segregating loss-of-function PRPS1 variants and concordant functional data in patient cells and animal models Genetic EvidenceStrongPathogenic missense variants identified in ≥5 probands across 4 pedigrees with X-linked recessive inheritance; segregation in 3 maternal uncles ([PMID:27256512]) Functional EvidenceModerateIn vitro assays show marked reduction of PRPP synthetase 1 activity in patient cells ([PMID:17701896]); zebrafish prps1a/b mutants recapitulate core clinical features ([PMID:27425195]) |